OPCM has created the first predictive analytics solution that can identify the unnecessary costs of opioids inside of employer health plans up to five (5) months before any solution on the market.   Opioid over-prescribing costs’ employers $60.0B each year, increasing the health insurance costs for over 150 million employees in the U.S.  Saving money, saving lives.

Michael Vasquez started his career as a software developer, taking the first electronic medical record company with artificial intelligence(AI) in America public in 1995.   Later, impacted by the death of a family friend, Vasquez and his wife created one of the largest drug treatment programs in the country, treating 10,000 people and detoxing over 2,500 opioid addicted patients.   Combining his software skills with his knowledge of addiction and treatment, Vasquez founded Opioid Clinical Management in 2017.

In the U.S., 130 people die each day from an opioid overdose. That’s 130 family members, 130 friends, 130 neighbors, 130 coworkers. Each and every day. The loss of 47,000 lives each year is staggering and that toll is likely to rise.

The loss of human life is heartbreaking, though that’s just part of the impact. Opioid abuse costs employers $10 billion dollars in missed workdays alone.  Employees on long-term narcotics are 3X more likely to be out sick or late, 5X more likely to file a workers’ comp claim, 4X more likely to have an accident on the job, and 2X more likely to change jobs.

Opioid use also contributes to the rising cost of health insurance. Up to 4% of those covered by a company health plan add unnecessary costs due to opioid prescriptions, adding up to 15% of the plans’ cost every year.

These expenses can begin to affect health plan costs five months prior to any formal diagnosis of opioid misuse or abuse, but employers, until now, have had no way to identify or intervene.

In addition, with the outbreak of the corona virus and the necessary focus to flatten the Covid-19 curve, the opioid epidemic and its costs are set to exceed $60 billion in unnecessary health plan costs as the country returns to a new normal.  

Opioid Clinical Management (OPCM) has discovered a way to stop the struggle before a user’s opioid battle becomes overwhelming.

Our solution uses analytics to examine clinical indicators and  pharmaceutical claims paid by an employer’s health plan to identify patients who may have a unnecessary cost or struggle with their opioid prescription.

We also identify the physician who wrote the prescription. OPCM pharmacists reach out to providers, encouraging compliance with CDC guidelines and alerting them to the employer’s use of our monitoring analytics.  Helping to avoid unnecessary prescription costs.

OPCM’s numbers speak for themselves. Our first client saw a 64% reduction in unnecessary opioid prescriptions in just six months, reducing the per user cost by $7,000 and saving more than $1.3 million dollars.

This early intervention doesn’t just save money. It saves family members, friends, neighbors and coworkers. Saving money, saving lives.

Since our founding in late 2017, Opioid Clinical Management has already made strides toward helping to mitigate opioid abuse and its significant cost in both dollars and lives.

Michael Vasquez | Founder/CEO/Director
Michael Vasquez - Since 1986 Mr. Vasquez has been the founder of industry changing healthcare technology companies in the United States.  Including PACE Health Management (IPO, sold to 3M), CareMedic Systems (sold to United Healthcare), Harbor View Medical (sold to Regenexx), and St. Gregory Retreat Centers (sold to Summit BHC), He holds an Executive Health Management Certificate from the Harvard School of Public Health. Vasquez was named Entrepreneur of the Year by Ernst & Young and was inducted into the E&Y Entrepreneur of the Year Hall of Fame.

Joseph Teeling | COO
Joseph Teeling started his career in sales, honing his expertise and serving in a variety of executive leadership roles. Teeling was Chairman/CEO of Bearance Management Group, growing the company to a top 200 insurance broker. He also spent more than two decades with Marsh & McLennon Companies and served as President of Marsh Advantage America.

Brian Thompson | CFO
Brian Thompson has more than 26 years of executive leadership, financial, operational and merger and acquisition experience. He previously served as CFO of Advanced Analytical Technologies, SVP of Equity Dynamics, CFO/CAO for Kum & Go and President/CFO of Astracon, Inc., as well as a Partner/CFO of Edgewater Funds.